Showing results (911-920 of 947) with videos related to
Sort By:
Pageof 95
Data and Information Management|April 6, 2022
Building an Open Resources Repository for COVID-19 ResearchTao Hu, Weihe Wendy Guan, Xinyan Zhu, et al.Oncotarget|March 13, 2015
Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemiaAlisa B Lee-Sherick, Weihe Zhang, Kelly K Menachof, et al.International Journal of Circumpolar Health|July 10, 2024
Updated review on contaminant communication experiences in the circumpolar ArcticEva M Krümmel, Amanda D Boyd, Danielle Brandow, et al.Journal of Medicinal Chemistry|July 29, 2014
UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitorWeihe Zhang, Deborah DeRyckere, Debra Hunter, et al.Breast Cancer Research : BCR|February 26, 2024
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancerRebecca A Shatsky, Hemali Batra-Sharma, Teresa Helsten, et al.Neurology|September 9, 2011
Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trialN Sacktor, S Miyahara, L Deng, et al.European Journal of Medicinal Chemistry|May 23, 2013
UNC1062, a new and potent Mer inhibitorJing Liu, Weihe Zhang, Michael A Stashko, et al.Annals of Intensive Care|March 2, 2023
Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trialSandra Jonmarker, Felix Alarcón, Jacob Litorell, et al.Nature Communications|March 31, 2018
Chemical tunnel-splitting-engineering in a dysprosium-based molecular nanomagnetMikkel A Sørensen, Ursula B Hansen, Mauro Perfetti, et al.JCI Insight|May 10, 2016
The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemiaKatherine A Minson, Catherine C Smith, Deborah DeRyckere, et al.Pageof 95